» Articles » PMID: 23495939

CRISPR-mediated Adaptive Immune Systems in Bacteria and Archaea

Overview
Publisher Annual Reviews
Specialty Biochemistry
Date 2013 Mar 19
PMID 23495939
Citations 323
Authors
Affiliations
Soon will be listed here.
Abstract

Effective clearance of an infection requires that the immune system rapidly detects and neutralizes invading parasites while strictly avoiding self-antigens that would result in autoimmunity. The cellular machinery and complex signaling pathways that coordinate an effective immune response have generally been considered properties of the eukaryotic immune system. However, a surprisingly sophisticated adaptive immune system that relies on small RNAs for sequence-specific targeting of foreign nucleic acids was recently discovered in bacteria and archaea. Molecular vaccination in prokaryotes is achieved by integrating short fragments of foreign nucleic acids into a repetitive locus in the host chromosome known as a CRISPR (clustered regularly interspaced short palindromic repeat). Here we review the mechanisms of CRISPR-mediated immunity and discuss the ecological and evolutionary implications of these adaptive defense systems.

Citing Articles

Lineage-specific variation in frequency and hotspots of recombination in invasive Escherichia coli.

Piper K, Souza S, Ikhimiukor O, Workman A, Martin I, Andam C BMC Genomics. 2025; 26(1):190.

PMID: 39994515 PMC: 11853335. DOI: 10.1186/s12864-025-11367-6.


Genome editing for grass improvement and future agriculture.

Bilal M, Geng J, Chen L, Garcia-Caparros P, Hu T Hortic Res. 2025; 12(2):uhae293.

PMID: 39906167 PMC: 11789526. DOI: 10.1093/hr/uhae293.


Adaptive loss of tRNA gene expression leads to phage resistance in a marine Synechococcus cyanobacterium.

Zborowsky S, Tahan R, Lindell D Nat Microbiol. 2025; 10(1):66-76.

PMID: 39753669 PMC: 11726456. DOI: 10.1038/s41564-024-01877-6.


Bacterial Shedu immune nucleases share a common enzymatic core regulated by diverse sensor domains.

Gu Y, Li H, Deep A, Enustun E, Zhang D, Corbett K Mol Cell. 2025; 85(3):523-536.e6.

PMID: 39742666 PMC: 11805627. DOI: 10.1016/j.molcel.2024.12.004.


Improving the use of CRISPR/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine.

Fatima H, Singh D, Muhammad H, Acharya S, Aziz M 3 Biotech. 2024; 15(1):17.

PMID: 39711922 PMC: 11656010. DOI: 10.1007/s13205-024-04186-1.